Literature DB >> 23912602

Malignant transformation of metachronous bilateral Schneiderian inverted papilloma of the lacrimal sac: management considerations and the contentious issue of orbital exenteration.

Shofiq Islam1, Robert L Eisenberg, Gary R Hoffman.   

Abstract

The authors present an unusual case of malignant transformation of metachronous bilateral Schneiderian inverted papilloma (IP) of the lacrimal sac. Such pathology has been sparingly covered in prior published literature, in particular with little formal discussion surrounding its optimal management. We describe the clinical presentation, course and management in a 35-year-old male with histopathological diagnosis of Squamous cell carcinoma (SCC) arising within IP. He underwent radical surgery, including orbital exenteration and medial maxillectomy. Our patient re-presented with IP in the contralateral side and subsequent malignant transformation to SCC with disseminated disease. Unfortunately he succumbed to disease approximately 20 months following initial surgery. This case raises several important questions with regard to appropriate treatment. In particular, we discuss the various management options with special consideration given to the contentious topic of orbital exenteration in such patients. We emphasise two particular controversial issues, namely, oncological efficacy of orbital preservation and the functional compromise that may result in the preserved eye.

Entities:  

Mesh:

Year:  2013        PMID: 23912602     DOI: 10.1007/s00405-013-2632-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

Review 1.  Schneiderian papillomas and nonsalivary glandular neoplasms of the head and neck.

Authors:  Leon Barnes
Journal:  Mod Pathol       Date:  2002-03       Impact factor: 7.842

2.  Orbital exenteration: a 10-year experience of a general oncology hospital.

Authors:  Hülya Gökmen Soysal
Journal:  Orbit       Date:  2010-06

3.  Malignant lacrimal sac tumors.

Authors:  A Montalban; B Liétin; C Louvrier; M Russier; J-L Kemeny; T Mom; L Gilain
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2010-10-29       Impact factor: 2.080

4.  Diagnosis and management of mucoepidermoid carcinoma of the lacrimal duct.

Authors:  Sonia T Brar; Dale Meyer
Journal:  Orbit       Date:  2011-01

5.  Orbital exenteration in periorbital malignancies.

Authors:  Phoebe Roche; Conrad Timon
Journal:  Surgeon       Date:  2011-05-04       Impact factor: 2.392

6.  Surgical management of transitional cell carcinoma of the lacrimal sac: Is it time for a new treatment algorithm?

Authors:  Shofiq Islam; Alexandria Thomas; Robert L Eisenberg; Gary R Hoffman
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-10-08       Impact factor: 2.740

7.  Development of a staging system for inverted papilloma.

Authors:  J H Krouse
Journal:  Laryngoscope       Date:  2000-06       Impact factor: 3.325

8.  Management of the orbit in malignant sinonasal tumors.

Authors:  Carlos Suárez; Alfio Ferlito; Valerie J Lund; Carl E Silver; Johannes J Fagan; Juan Pablo Rodrigo; José L Llorente; Giulio Cantù; Massimo Politi; William I Wei; Alessandra Rinaldo
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

Review 9.  Risks of malignancy in inverted papilloma of the nose and paranasal sinuses.

Authors:  Christian von Buchwald; Patrick J Bradley
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2007-04       Impact factor: 2.064

10.  The eye amputated - consequences of eye amputation with emphasis on clinical aspects, phantom eye syndrome and quality of life.

Authors:  Marie Louise Roed Rasmussen
Journal:  Acta Ophthalmol       Date:  2010-12       Impact factor: 3.761

View more
  1 in total

1.  Clinical evidence based review and systematic scientific review in the identification of malignant transformation of inverted papilloma.

Authors:  Cai Long; Basel Jabarin; Alexandra Harvey; Jennifer Ham; Amin Javer; Arif Janjua; Andrew Thamboo
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.